161 related articles for article (PubMed ID: 38089646)
1. Case report: Squamous cell carcinoma of the prostate-a clinicopathological and genomic sequencing-based investigation.
Zhang C; Jia Y; Kong Q
Pathol Oncol Res; 2023; 29():1611343. PubMed ID: 38089646
[TBL] [Abstract][Full Text] [Related]
2. Metastatic squamous cell carcinoma transformed from prostatic adenocarcinoma following androgen deprivation therapy: A case report with clinicopathologic and molecular findings.
Lau HD; Clark M
Diagn Cytopathol; 2020 Dec; 48(12):E14-E17. PubMed ID: 32628337
[TBL] [Abstract][Full Text] [Related]
3. Small cell carcinoma of the prostate.
Nadal R; Schweizer M; Kryvenko ON; Epstein JI; Eisenberger MA
Nat Rev Urol; 2014 Apr; 11(4):213-9. PubMed ID: 24535589
[TBL] [Abstract][Full Text] [Related]
4. Whole exome sequencing of lung adenocarcinoma and lung squamous cell carcinoma in one individual: A case report.
Bai Y; Xu Y; Wang X; Liu Y; Sun C; Guo Y; Cai Y; Shao G; Yang Z; Qiu S; Ma K
Thorac Cancer; 2020 Aug; 11(8):2361-2364. PubMed ID: 32578383
[TBL] [Abstract][Full Text] [Related]
5. Case Report: Systemic Treatment and Serial Genomic Sequencing of Metastatic Prostate Adenocarcinoma Progressing to Small Cell Carcinoma.
Lu X; Gao W; Zhang Y; Wang T; Gao H; Chen Q; Shi X; Lian B; Zhang W; Gao X; Li J
Front Oncol; 2021; 11():732071. PubMed ID: 34646773
[TBL] [Abstract][Full Text] [Related]
6. Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database.
Keto CJ; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
BJU Int; 2012 Aug; 110(4):492-8. PubMed ID: 22094083
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators.
Wei L; Wang J; Lampert E; Schlanger S; DePriest AD; Hu Q; Gomez EC; Murakam M; Glenn ST; Conroy J; Morrison C; Azabdaftari G; Mohler JL; Liu S; Heemers HV
Eur Urol; 2017 Feb; 71(2):183-192. PubMed ID: 27451135
[TBL] [Abstract][Full Text] [Related]
8. Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy.
Wilkinson S; Ye H; Karzai F; Harmon SA; Terrigino NT; VanderWeele DJ; Bright JR; Atway R; Trostel SY; Carrabba NV; Whitlock NC; Walker SM; Lis RT; Abdul Sater H; Capaldo BJ; Madan RA; Gulley JL; Chun G; Merino MJ; Pinto PA; Salles DC; Kaur HB; Lotan TL; Venzon DJ; Choyke PL; Turkbey B; Dahut WL; Sowalsky AG
Eur Urol; 2021 Dec; 80(6):746-757. PubMed ID: 33785256
[TBL] [Abstract][Full Text] [Related]
9. Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma.
Tamura R; Nakaoka H; Yachida N; Ueda H; Ishiguro T; Motoyama T; Inoue I; Enomoto T; Yoshihara K
Cancer Sci; 2023 May; 114(5):2145-2157. PubMed ID: 36762791
[TBL] [Abstract][Full Text] [Related]
10. The heterogeneity and clonal evolution analysis of the advanced prostate cancer with castration resistance.
Liu A; Gao Y; Wang Q; Lin W; Ma Z; Yang X; Chen L; Xu D
J Transl Med; 2023 Sep; 21(1):641. PubMed ID: 37726835
[TBL] [Abstract][Full Text] [Related]
11. Genomic Evolution and Transcriptional Changes in the Evolution of Prostate Cancer into Neuroendocrine and Ductal Carcinoma Types.
Rao SR; Protheroe A; Cerundolo L; Maldonado-Perez D; Browning L; Lamb AD; Bryant RJ; Mills IG; Woodcock DJ; Hamdy FC; Tomlinson IPM; Verrill C
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628903
[TBL] [Abstract][Full Text] [Related]
12. Novel candidate genes may be possible predisposing factors revealed by whole exome sequencing in familial esophageal squamous cell carcinoma.
Forouzanfar N; Baranova A; Milanizadeh S; Heravi-Moussavi A; Jebelli A; Abbaszadegan MR
Tumour Biol; 2017 May; 39(5):1010428317699115. PubMed ID: 28459198
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive serial molecular profiling of an "N of 1" exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatment.
Kadakia KC; Tomlins SA; Sanghvi SK; Cani AK; Omata K; Hovelson DH; Liu CJ; Cooney KA
J Hematol Oncol; 2015 Oct; 8():109. PubMed ID: 26444865
[TBL] [Abstract][Full Text] [Related]
14. Primary squamous cell carcinoma of the prostate: a rare clinicopathological entity. Report of 2 cases and review of literature.
Nabi G; Ansari MS; Singh I; Sharma MC; Dogra PN
Urol Int; 2001; 66(4):216-9. PubMed ID: 11385309
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy.
Karnes RJ; Sharma V; Choeurng V; Ashab HA; Erho N; Alshalalfa M; Trock B; Ross A; Yousefi K; Tsai H; Zhao SG; Tosoian JJ; Haddad Z; Takhar M; Chang SL; Spratt DE; Abdollah F; Jenkins RB; Klein EA; Nguyen PL; Dicker AP; Den RB; Davicioni E; Feng FY; Lotan TL; Schaeffer EM
Clin Cancer Res; 2018 Aug; 24(16):3908-3916. PubMed ID: 29760221
[No Abstract] [Full Text] [Related]
16. Prostate carcinoma with squamous differentiation: an analysis of 33 cases.
Parwani AV; Kronz JD; Genega EM; Gaudin P; Chang S; Epstein JI
Am J Surg Pathol; 2004 May; 28(5):651-7. PubMed ID: 15105655
[TBL] [Abstract][Full Text] [Related]
17. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial.
Boevé LMS; Hulshof MCCM; Vis AN; Zwinderman AH; Twisk JWR; Witjes WPJ; Delaere KPJ; Moorselaar RJAV; Verhagen PCMS; van Andel G
Eur Urol; 2019 Mar; 75(3):410-418. PubMed ID: 30266309
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms underlying the development of neuroendocrine prostate cancer.
Liu S; Alabi BR; Yin Q; Stoyanova T
Semin Cancer Biol; 2022 Nov; 86(Pt 3):57-68. PubMed ID: 35597438
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and Therapeutic Challenges in a Patient with Synchronous Very High-Risk Prostate Adenocarcinoma and Anal Carcinoma.
Wallach J; Youssef I; Leaf A; Schwartz D
Curr Oncol; 2022 Jan; 29(1):377-382. PubMed ID: 35049707
[TBL] [Abstract][Full Text] [Related]
20. [Squamous cell carcinoma of the prostate: a further case].
Herrera Puerto J; Barragán Casas JM; Hoyos Fitto C; Isusquiza Garro I; Pierna Manzano J
Actas Urol Esp; 2002 May; 26(5):366-8. PubMed ID: 12174747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
